Calipage Run 2019 for the benefit of Immuno-T by prof. Tessa Kerre

The benefits of the 16th Calipage Run are for the research of Prof. Tessa Kerre into cancer immunotherapy and the impact of properly informing patients and their loved ones about the disease and treatment.

Immunotherapy as a new form of treating cancer engages the patient's own immune system to attack and kill the cancer cells. There are different forms of immunotherapy, all of which are complex and not easy to explain. To this end, CRIG group leader Prof. Tessa Kerre developed Immuno-T, a motion comic that explains in a clear and simple way how different forms of immunotherapy work. More information: visit the Immuno-T website and download the motion comic!

Extra financial resources are required for the further development of Immuno-T, and therefore the benefits of the Calipage Run 219 will be very welcome.

Calipage Run 2019: